C3 glomerulopathy.

C3 glomerulopathy is a group of related conditions that cause the kidneys to malfunction. The major features of C3 glomerulopathy include high levels of protein in the urine (proteinuria), blood in the urine (hematuria), reduced amounts of urine, low levels of protein in the blood, and swelling in many areas of the body. Affected individuals may have particularly low levels of a protein called complement component 3 (or C3) in the blood.

[1]  M. Okrój,et al.  Nephritic Factors: An Overview of Classification, Diagnostic Tools and Clinical Associations , 2019, Front. Immunol..

[2]  G. Appel,et al.  Kidney Transplantation in C3 Glomerulopathy: A Case Series. , 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  Richard J. H. Smith,et al.  C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic , 2018, Mayo Clinic proceedings.

[4]  G. Remuzzi,et al.  Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN. , 2017, Journal of the American Society of Nephrology : JASN.

[5]  F. Petitprez,et al.  Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy. , 2017, Blood.

[6]  G. Ardissino,et al.  Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. , 2017, Kidney international.

[7]  M. Keswani,et al.  Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy , 2016, Clinical kidney journal.

[8]  D. Kolbe,et al.  High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies. , 2016, Journal of the American Society of Nephrology : JASN.

[9]  M. Ruseva,et al.  Update on C3 glomerulopathy , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  K. Nath,et al.  Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach. , 2015, Journal of the American Society of Nephrology : JASN.

[11]  Richard J. H. Smith,et al.  C3 Glomerulopathy: The Genetic and Clinical Findings in Dense Deposit Disease and C3 Glomerulonephritis , 2014, Seminars in Thrombosis & Hemostasis.

[12]  P. O'kelly,et al.  C3 glomerulopathy: clinicopathologic features and predictors of outcome. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[13]  Richard J. H. Smith,et al.  C3 Glomerulopathy: The Genetic and Clinical Findings in Dense Deposit Disease and C3 Glomerulonephritis , 2014, Seminars in Thrombosis & Hemostasis.

[14]  V. D’Agati,et al.  C3 glomerulopathy: consensus report , 2013, Kidney international.

[15]  J. Grünfeld,et al.  Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. , 2012, Kidney international.

[16]  L. Katz,et al.  Allelic Variants of Complement Genes Associated with Dense Deposit Disease , 2011, Journal of the American Society of Nephrology : JASN.

[17]  V. Frémeaux-Bacchi,et al.  C3 glomerulopathy: a new classification , 2010, Nature Reviews Nephrology.